Enlivex Therapeutics Ltd. (ENLV) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

Enlivex Therapeutics Ltd.

NASDAQ: ENLV · Real-Time Price · USD
1.03
0.00 (0.00%)
At close: Sep 26, 2025, 3:56 PM
1.02
-0.97%
Pre-market: Sep 29, 2025, 05:13 AM EDT

Enlivex Therapeutics Revenue

Enlivex Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, Enlivex Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
71
Market Cap
24.56M

Revenue Chart

History

Fiscal Year End Revenue % Change
Dec 31, 2024 0 n/a
Dec 31, 2023 0 n/a
Dec 31, 2022 0 n/a
Dec 31, 2021 0 -100.00%
Dec 31, 2020 2.28M +Infinity%
Dec 31, 2019 0 n/a
Dec 31, 2018 0 n/a
Dec 31, 2017 0 n/a
Dec 31, 2016 0 n/a
Dec 31, 2015 0 n/a
Dec 31, 2014 0 n/a
Dec 31, 2013 0 n/a
Dec 31, 2012 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.